A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer.

Zicheng WangYifei ZhangChangqin JiangBinbin Gong

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

The immune-related RBPs' signature is an independent prognostic marker that could help screen patients with advanced prostate cancer who are better suited for targeted and immunotherapy.

Keyphrases

prostate cancer
radical prostatectomy
high throughput
cancer therapy
drug induced